Canada’s Glycomics Research
Harnessing the power of glycomics
In 2024, 5 of the top 10 selling drugs are glycosylated and have a combined revenue of $76 billion USD.
Global market for glycomics drugs to reach $257 billion USD by 2028.
Network Investigators
0
Funded Projects
0
Trained HQP
0
Network Partners
0
GlycoNet advances research, innovation, and training in glycomics to improve the quality of life of Canadians.
GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training of a new generation of glyco-scientists and entrepreneurs. The network includes over 200 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.
GlycoNet is funded in part by the Government of Canada through the Strategic Science Fund and the Canada Foundation for Innovation’s Major Science Initiatives Fund.
GlycoNet Integrated Services
GlycoNet Integrated Services (GIS) is Canada’s only and one of the world’s leading glycomics platforms. As a core facility centralized at GlycoNet and housed at research institutions across Canada, our experts are at the forefront of glycomics research and are continually improving, expanding, and optimizing methods and technologies.
GIS is supported in part by the Canada Foundation for Innovation’s Major Science Initiatives Fund (2023-2029).
Services
- Glycan–Ligand Screening and Discovery
- Glycan Analysis
- Carbohydrate Synthesis
- Drug Discovery & High-Throughput Screening (HTS)
- Molecular Glycobiology & Glycoengineering
Our services, instruments, technologies and professional services are available to all researchers, from Canada and abroad, across academic, private, and government sectors. The facility’s scientific and technical personnel provides high-quality, high-throughput, and competitively priced products and services to all of its clients.
CGS 2027 will take place May 11-14, 2027 in Canmore, Alberta.
Stay tuned for details!
Featured Reports
Glycomics: The New Frontier in Bioinnovation
Why glycomics, the study of sugars on cells, is at the centre of a new surge of scientific and industry interest.
2026 Annual Report
Strengthening Canada's health resilience, food security, and bioeconomy
Latest News
GlycoNet welcomes two new members to its Board of Directors
André Vincent and Stephen Sampson bring extensive experience in governance, risk management, and public affairs.
Read More
GlycoNet startup Avivo awarded $10.9 M to advance technology for universal blood and organs
Avivo was one of five companies selected for funding under the Government of Canada's Life Sciences Fund to advance dual-use innovations and strengthen Canada's industrial ...
Read More
GlycoNet Investigators inducted into the Royal Society of Canada
Congratulations to Drs. Jason Acker and Lara Mahal on receiving Canada's highest academic honour.
Read More
Glycomics in Action: Powering the Next Wave of Biotech Breakthroughs
In the most recent issue of BIOTECanada’s Insights Magazine, we talk about how Canada’s glycomics ecosystem is helping move complex sugar science from the lab ...
Read More
